Neurobehavioral Disorders: Mapping Biomarkers for Preclusion
Abstract
Keywords
Full Text:
PDFReferences
REFERENCES
What to Know About Neurobehavioral Disorders. Verywell Mind 2021.
https://www.verywellmind.com/neurobehavioral-disorders-definition-causes-coping-5203985.
Norwood | May Center School for Brain Injury and Neurobehavioral Disorders [Internet]. Norwood
| May Center School for Brain Injury and Neurobehavioral Disorders. Available from:
https://www.mayinstitute.org/locations/ma/brockton-may-center-school-for-brain-injury-and-
neurobehavioral-disorders/
Zasler ND, Martelli MF, Jacobs HE. Neurobehavioral disorders. Handb Clin Neurol. 2013;
:377-88.
Volkow ND, Koob G, Baler R. Biomarkers in substance use disorders. ACS Chem Neurosci. 2015;
(4):522-5.
Ewen JB, Levin AR. Neurobehavioral Biomarkers: An EEG Family Reunion. J Clin Neurophysiol.
; 39(2):129-134.
Simone M, De Giacomo A, Palumbi R, Palazzo C, Lucisano G, Pompamea F, Micella S, Pascali M,
Gabellone A, Marzulli L, Giordano P, Gargano CD, Margari L, Frigeri A, Ruggieri M. Serum
Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers
in Autism Spectrum Disorders: A Preliminary Study. Int J Mol Sci. 2023; 24(3):3057.
Tremblay MW, Jiang YH. DNA Methylation and Susceptibility to Autism Spectrum Disorder. Annu
Rev Med. 2019 Jan 27; 70:151-166.
Nisar S, Haris M. Neuroimaging genetics approaches to identify new biomarkers for the early
diagnosis of autism spectrum disorder. Mol Psychiatry. 2023; 17:1-4.
LaSalle JM. Epigenomic signatures reveal mechanistic clues and predictive markers for autism
spectrum disorder. Mol Psychiatry. 2023; 17:1-2.
Takahashi N, Ishizuka K, Inada T. Peripheral biomarkers of attention-deficit hyperactivity disorder:
Current status and future perspective. J Psychiatr Res. 2021; 137:465-470.
Chen H, Yang Y, Odisho D, Wu S, Yi C, Oliver BG. Can biomarkers be used to diagnose attention
deficit hyperactivity disorder? Front Psychiatry. 2023; 14:1026616.
Cecil CAM, Nigg JT. Epigenetics and ADHD: Reflections on Current Knowledge, Research
Priorities and Translational Potential. Mol Diagn Ther. 2022 Nov;26(6):581-606.
Tang Y, Gui H, Tarbox-Berry S, Hu S, Ma X, Wang Q. Genetic Mechanisms of Biomarkers in
Schizophrenia, Bipolar Disorder and Depression. Front Psychiatry. 2021; 12:736055.
Galderisi S, DeLisi LE, Borgwardt S, editors. Neuroimaging of schizophrenia and other primary
psychotic disorders: achievements and perspectives.
Galińska-Skok B, Waszkiewicz N. Markers of Schizophrenia-A Critical Narrative Update. J Clin
Med. 2022; 11(14):3964.
Dinakaran D, Sreeraj VS, Venkatasubramanian G. Biological Markers for Outcome and Recovery
in Schizophrenia. Schizophrenia Treatment Outcomes: An Evidence-Based Approach to Recovery.
; 85-9.
Fullana MA, Abramovitch A, Via E, et al. Diagnostic biomarkers for obsessive-compulsive
disorder: A reasonable quest or ignis fatuus? Neurosci Biobehav Rev. 2020; 118:504-513.
Bruin WB, Taylor L, Thomas RM, et al. Structural neuroimaging biomarkers for obsessive-
compulsive disorder in the ENIGMA-OCD consortium: medication matters. Transl Psychiatry.
; 10(1):342.
Research & Reviews: A Journal of Neuroscience
Volume 13, Issue 2
ISSN: 2277-6427 (Online), ISSN: 2348-7925 (Print)
© STM Journals 2023. All Rights Reserved 23
Herzog SA, and Brakoulias V. The Role of Neurophysiological Biomarkers in Obsessive-
Compulsive Disorder. Curr Med Chem. 2022; 29(35):5584-5594.
Alghadir AH, Gabr SA. Physical activity impact on motor development and oxidative stress
biomarkers in school children with intellectual disability. Rev Assoc Med Bras (1992). 2020;
(5):600-606.
Sengupta A, Das U, Manna K, et al. An association study of severity of intellectual disability with
peripheral biomarkers of disabled children in a rehabilitation home, Kolkata, India. Sci Rep. 2019;
(1):13652.
Ewen JB, Potter WZ, Sweeney JA. Biomarkers and neurobehavioral diagnosis. Biomark
Neuropsychiatry. 2021 Jun; 4:100029.
Dunckley T, Coon KD, Stephan DA. Discovery and development of biomarkers of neurological
disease. Drug Discov Today. 2005; 10(5):326-34.
Quatieri TF, Williamson JR, Lambert AC. Non-invasive Biomarkers of Neurobehavioral
Performance. Lincoln Lab J. 2020; 24(1):28-59.
Kong X, Liu J, Cetinbas M, et al. New and preliminary evidence on altered oral and gut microbiota
in individuals with autism spectrum disorder (ASD): implications for ASD diagnosis and subtyping
based on microbial biomarkers. Nutrients. 2019; 11(9):2128.
Mazón-Cabrera R, Liesenborgs J, Brône B, et al. Novel maternal autoantibodies in autism spectrum
disorder: Implications for screening and diagnosis. Front Neurosci. 2023 Feb 2; 17:1067833.
Stoccoro A, Conti E, Scaffei E, Calderoni S, et al. DNA Methylation Biomarkers for Young
Children with Idiopathic Autism Spectrum Disorder: A Systematic Review. Int J Mol Sci. 2023 May
;24(11):9138.
Beversdorf DQ, Anagnostou E, Hardan A, Wang P, Erickson CA, Frazier TW, Veenstra-Vander.
Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders
(The need for a biomarker exploration phase in clinical trials-Phase 2m). Frontiers in Psychiatry.
; 13:1079006.
Dargenio VN, Dargenio C, Castellaneta S, et al. Intestinal Barrier Dysfunction and Microbiota-Gut-
Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder.
Nutrients. 2023; 15(7):1620.
Arpawong TE, Klopack ET, Kim JK, et al. ADHD genetic burden associates with older epigenetic
age: mediating roles of education, behavioral and sociodemographic factors among older adults.
Clin Epigenetics. 2023; 15(1):67.
Grossman S and Berger I. Inclusion of a Computerized Test in ADHD Diagnosis Process can
Improve Trust in the Specialists' Decision and Elevate Compliance Levels. 2023, PREPRINT
(Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-2895273/v1]
Cao M, Martin E, Li X. Machine learning in attention-deficit/hyperactivity disorder: new
approaches toward understanding the neural mechanisms. Transl Psychiatry. 2023; 13(1):236.
Wang Y, Fang X, Wang G, et al. The association between inflammation and kynurenine pathway
metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy. Brain
Behav Immun. 2023; 113:1-11.
Amer, M, Amer, R, Ahmed H, Antiphospholipid antibodies as biomarkers for schizophrenia. Int J
Res Psychiatry. 2023; 3(1):01-08.
Zhang HC, Du Y, Chen L, etal. MicroRNA schizophrenia: Etiology, biomarkers and therapeutic
targets. Neurosci Biobehav Rev. 2023; 146:105064.
Carmeli E, Imam B, Bachar A, Merrick J. Inflammation and oxidative stress as biomarkers of
premature aging in persons with intellectual disability. Res Dev Disabil. 2012; 33(2):369-75.
McManus BM and Nugent JK. A neurobehavioral intervention incorporated into a state early
intervention program is associated with higher perceived quality of care among parents of high-risk
newborns. J Behav Health Serv Res. 2014; 41(3):381-9.
Camerota M, McGowan EC, Carter BS, et al. Maternal Prenatal Risk Phenotypes and
Neurobehavioral Outcomes among Infants Born Very Preterm. The J Ped. 2023; 260:113521.
Neurobehavioral Disorders: Mapping Biomarkers for Preclusion Balekar et al.
© STM Journals 2023. All Rights Reserved 24
Wang CP, Tian Y. Effects of Maternal Environmental Exposure on Early Life Growth and
Development. In Utero Ped: Res & P 2023; 17:29-48.
Shang M, Tang M, Xue Y. Neurodevelopmental toxicity induced by airborne particulate matter. J
Appl Toxicol. 2023; 43(1):167-185.
Spittle A and Treyvaud K. The role of early developmental intervention to influence
neurobehavioral outcomes of children born preterm. Semin Perinatol. 2016; 40(8):542-548.
Cai Y, Liu P, Zhou X, et al. Probiotics therapy show significant improvement in obesity and
neurobehavioral disorders symptoms. Front Cell Infect Microbiol. 2023; 13:1178399.
Hu Y, Xing B, Wang H, et al. Screen Time and Children: The Relationship between Preschool
Children’s Household Screen Media Experience and Executive Functioning. Open J So Sci. 2023
Jun 7; 11(6):470-85.
Skalidou S, Anestis A, Bakolas N, et al. Swimming Activity Alleviates the Symptoms of Attention:
Deficit Hyperactivity Disorder (ADHD) A Case Report. In Healthcare 2023; 11(14):1999.
Singh S. Chess and the human brain-Demystifying the therapeutic value of a board game. J High
School Sci. 2023; 7(3).
Kip E and Parr-Brownlie LC. Healthy lifestyles and wellbeing reduce neuroinflammation and
prevent neurodegenerative and psychiatric disorders. Front Neuro. 2023; 17:1092537.
Curtis K, Weinrib A, Katz J. Systematic review of yoga for pregnant women: current status and
future directions. Evid Based Complement Alternat Med. 2012; 2012:715942.
DOI: https://doi.org/10.37591/rrjon.v13i2.3223
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Research & Reviews: Journal of Neuroscience